may 22 semaglutide Compounders fight back: “Novo is filing lawsuits to protect its profits” Semaglutide Microdose | GoodGirlRx

You can inject these shots anywhere on your body and administer them yourself at home

They dont take away the pleasure, they take away the exaggerated salience, the exaggerated anticipation

45.3% of participants on the highest dose lost 30% or more of their body weight TRIUMPH-4 knee osteoarthritis + obesity (Dec 2025) 28.7% weight loss at 68 weeks TRANSCEND-T2D-1 type 2 diabetes (Mar 19, 2026) A1C -2.0%, 16.8% weight loss at 40 weeks ADA 86th Scientific Sessions (Jun 6-10, 2026, New Orleans) the full TRIUMPH-1 + TRANSCEND-T2D-1 panel, the most detailed public presentation of the Phase 3 data see our ADA 2026 retatrutide coverage Still expected in 2026: TRIUMPH-2 (obesity in type 2 diabetes, with a nested OSA protocol): extends the obesity case into the T2D population and supports a sleep-apnea indication

Semaglutide and progestin for prevention of endometrial cancer and uterine preservation (Trial ID: NCI202402675)

Ideal candidates may have a history of insulin resistance, a higher BMI, or difficulty controlling appetite

GLP-1 receptor agonists have transformed diabetes and weight management since their introduction, with semaglutide showing 15% average body weight reduction in clinical trials